VLA 0.00% $1.75 viralytics limited

I am pleasantly surprised regarding the IV Cavatak trial getting...

  1. 21 Posts.
    lightbulb Created with Sketch. 2
    I am pleasantly surprised regarding the IV Cavatak trial getting to the podium. Technically i had my doubts that IV Cavatak would "seed" tumours well enough to make a big difference vs the large amount of virus they can inject directly into multiple melanoma tumours. If they are seeing improved efficacy in lung CA combined with a checkpoint inhibitor... that changes the game completely regarding valuation.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.